Dr. Syed Khalid Mahmood, M.D Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2614 Jenks Ave, Panama City, FL 32405 Phone: 850-769-2996 Fax: 850-769-4665 |
Kelly Carver, D.O. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2100 State Ave, Panama City, FL 32405 Phone: 850-763-0036 Fax: 850-763-0259 |
Dr. Christopher Emil Haberman, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2100 State Ave, Panama City, FL 32405 Phone: 850-763-0036 Fax: 850-763-0259 |
Dr. Fernando C Malamud, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2202 State Ave, Suite 111, Panama City, FL 32405 Phone: 850-784-9977 |
Bruce W Porterfield, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2100 State Ave, Panama City, FL 32405 Phone: 850-763-0036 |
News Archive
In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.
Mitochondria are the body's energy producers, the power stations inside our cells. Researchers at the University of Gothenburg, Sweden, have now identified a group of mitochondrial proteins, the absence of which allows other protein groups to stabilise the genome. This could delay the onset of age-related diseases and increase lifespan.
Medicago Inc., a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it was included in a report of President Obama's Council of Advisors on Science and Technology entitled "Report to the President on Reengineering the Influenza Vaccine Production Enterprise to Meet the Challenges of Pandemic Influenza", which was released earlier this month. U.S. Health and Human Services Secretary Kathleen Sebelius and other public health officials held a briefing to discuss this report and the $2 billion plan to accelerate the development of drugs and vaccines to prevent the spread of infectious diseases.
As part of the new Exposure Biology Program, the National Institute of Environmental Health Sciences, a component of the National Institutes of Health, today announced $74 million in grant opportunities for the development of new technologies that will improve the measurement of environmental exposures that contribute to human disease.
In children with fever but no other symptoms of illness, it is difficult to know whether a child has a viral infection that will resolve on its own or a potentially serious bacterial infection that requires antibiotics.
› Verified 5 days ago